Oxford: Blackwell Scientific 1975 This interesting book presents a somewhat selective view of medical aspects of malignant diseases given by twenty-four contributors. Some of the biological processes involved in cancer and its metabolic effects are discussed in early chapters.
There are two helpful sections concerning diagnostic methods and the principles of therapy but the largest part of the book is concerned with the treatment of specific cancers. Much emphasis is placed on comparatively uncommon tumours but this is hardly surprising in view of the fact that treatment of these has been particularly successful and it is in these areas where greatest advances have been made. The final chapter on terminal care is written with characteristic compassion by Dr Cicely Saunders. This book fills a gap in the relatively sparse literature of oncology. It is easy to read but the index is confusing and could be improved. Certainly there is a good deal of interest for those whose work brings them into contact with patients suffering from all forms of cancer. The Group for Advancement of Psychiatry (GAP) is a US pressure group of 300 (out of 23 000) psychiatrists whose objectives are: to collect and appraise data; to revaluate old concepts and to develop and test new ones; and to apply the knowledge for better mental health. GAP have issued this pamphlet on the currently hot subject of 'recertification'. Recertification in narrow terms implies the reassessment, retesting and reexamination of established specialists holding American board certifications. The objectives are, from the profession's viewpoint, to encourage continuing education and to ensure that the doctor is up to date; from the public's viewpoint, to ensure that the doctor continues to be safe and knowledgeable; and from the government's viewpoint, that he is providing reasonable and good care.
The principle of recertification has been accepted by all the US specialty boards but only the American Board of Family Practice is putting the idea into practice by an MCQ recertifying exam from October 1976. GAP see many problems in recertification. First, is a legal one, whether professional and educational obsolescence can be used as a reason for revocation of a licence to practice. Second, is the problem that in psychiatry in USA less than one half of psychiatrists are Board certified and eligible for recertification. Third, they see many uncertainties in the methods of recertification and of the evaluative technologies that are used. These are described and considered.
In the end GAP recommends that there first has to be a much higher proportion of better trained and Board certified psychiatrists in USA. Then, once this has been achieved periodic voluntary recertification is put forward based on a minimal amount of approved continuing education, on MCQ tests, on assessment of interview techniques and psychotherapeutic skills and on audits of medical records.
From this report it is evident that the whole process of measurement of quality of doctors in USA is still in a confused and uncertain state in spite of all the activities over the years. Medica/North Holland 1976 This is a disappointing book for those of us who have been prescribing the monoamine oxidase inhibitors for the past fifteen years. The biochemistry articles would largely be understandable only by the biochemists themselves present at the symposium and none of the original research workers using these drugs such as Klein, West, Dally &c., who have had so much clinical experience, were invited to contribute. This means that the clinical aspects of these very valuable drugs discussed at the symposium are often below standard. We are not even told that the responders to the monoamine oxidase inhibitors are patients with anxiety states and depressions, who sleep heavily, and the tricyclics generally help only the early morning wakers. If the drug roles are reversed disaster can ensue, including attempted suicides, in both groups. There is no reference to combinations of
